The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Heart failure etiology and response tomilrinone in decompensated heart failure
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Research works printed but not linked: 29
- Adams, 1996, Relation between gender, etiology and survival in patients with symptomatic heart failure, J Am Coll Cardiol, 28, 1781, 10.1016/S0735-1097(96)00380-4 · DOI · Paper page
- Likoff, 1987, Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy, Am J Cardiol, 59, 634, 10.1016/0002-9149(87)91183-0 · DOI · Paper page
- Bart, 1997, Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy, J Am Coll Cardiol, 30, 1002, 10.1016/S0735-1097(97)00235-0 · DOI · Paper page
- Felker, 2000, Underlying cause and long-term survival in patients with initially unexplained cardiomyopathy, N Engl J Med, 42, 1077, 10.1056/NEJM200004133421502 · DOI · Paper page
- Follath, 1998, Etiology and response to drug treatment in heart failure, J Am Coll Cardiol, 32, 1167, 10.1016/S0735-1097(98)00400-8 · DOI
- O’Connor, 2000, Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure, Am Heart J, 138, 78, 10.1016/S0002-8703(99)70250-4 · DOI · Paper page
- Shipley, 1996, Milrinone, Am J Med Sci, 311, 286, 10.1016/S0002-9629(15)41723-9 · doi:10.1016/s0002-9629(15)41723-9
- Schulz, 1992, Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery, Circ Res, 70, 1282, 10.1161/01.RES.70.6.1282 · DOI · Paper page
- Schulz, 1993, Development of short-term myocardial hibernation, Circulation, 88, 684, 10.1161/01.CIR.88.2.684 · DOI · Paper page
- Indolfi, 1996, Inotropic stimulation by dobutamine increases left ventricular regional function at the expense of metabolism in hibernating myocardium, Am Heart J, 132, 542, 10.1016/S0002-8703(96)90236-7 · doi:10.1016/s0002-8703(96)90236-7
- Cuffe, 2002, Short-term intravenous milrinone for acute exacerbation of chronic heart failure, JAMA, 287, 1541, 10.1001/jama.287.12.1541 · DOI · Paper page
- Cuffe, 2000, Rationale and design of the OPTIME CHF trial, Am Heart J, 139, 15, 10.1016/S0002-8703(00)90303-X · DOI
- Polanczyk, 2000, Ten-year trends in hospital care for congestive heart failure, Arch Intern Med, 160, 325, 10.1001/archinte.160.3.325 · DOI
- 1987, Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med, 316, 1429, 10.1056/NEJM198706043162301 · DOI · Paper page
- 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II), Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 · DOI · Paper page
- 1999, Effect of metoprolol CR/XL in chronic heart failure, Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 · DOI · Paper page
- Cohn, 1998, A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure, N Engl J Med, 339, 1810, 10.1056/NEJM199812173392503 · DOI · Paper page
- Packer, 1991, Effect of oral milrinone on mortality in severe chronic heart failure, N Engl J Med, 325, 1468, 10.1056/NEJM199111213252103 · DOI · Paper page
- 1990, Xamoterol in severe heart failure, Lancet, 336, 1, 10.1016/0140-6736(90)91517-E · DOI · Paper page
- Uretsky, 1990, Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure, Circulation, 82, 774, 10.1161/01.CIR.82.3.774 · DOI · Paper page
- Gheorghiade, 1998, Chronic heart failure in the United States, Circulation, 97, 282, 10.1161/01.CIR.97.3.282 · DOI · Paper page
- Kloner, 1998, Medical and cellular implications of stunning, hibernation, and preconditioning, Circulation, 97, 1848, 10.1161/01.CIR.97.18.1848 · DOI · Paper page
- Al-Mohammad, 1998, Prevalence of hibernating myocardium in patients with severely impaired ischemic left ventricles, Heart, 80, 559, 10.1136/hrt.80.6.559 · doi:10.1136/hrt.80.6.559
- Singh, 2000, Adrenergic regulation of myocardial apoptosis, Cardiovasc Res, 45, 713, 10.1016/S0008-6363(99)00370-3 · DOI
- Singh, 1995, Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia, N Engl J Med, 333, 77, 10.1056/NEJM199507133330201 · DOI · Paper page
- Doval, 1994, Randomised trial of low-dose amiodarone in severe congestive heart failure, Lancet, 344, 493, 10.1016/S0140-6736(94)91895-3 · DOI · Paper page
- Felker, 2002, A standardized definition of ischemic cardiomyopathy for use in clinical research, J Am Coll Cardiol, 39, 210, 10.1016/S0735-1097(01)01738-7 · DOI
- Unverferth, 1983, The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy, Am Heart J, 105, 176, 10.1016/0002-8703(83)90305-8 · doi:10.1016/0002-8703(83)90305-8
- Pasternac, 1982, Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries, Circulation, 65, 778, 10.1161/01.CIR.65.4.778 · DOI · Paper page
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
Self-citation
Metadata
- Authors
- Felker, G. M., Benza, R. L., Chandler, A. B., Leimberger, J. D., Cuffe, M. S., Califf, R. M., Gheorghiade, M., & O’Connor, C. M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 41
- Issue
- 6
- Pages
- 997-1003
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W55026472
- Cited by
- 515
- References
- 2
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3790 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heart failure etiology and response tomilrinone in decompensated heart failure. https://app.cochat.ai/papers/10.1016/s0735-1097(02)02968-6
- The paper
- Felker, G. M., Benza, R. L., Chandler, A. B., Leimberger, J. D., Cuffe, M. S., Califf, R. M., Gheorghiade, M., & O’Connor, C. M. (2003). Heart failure etiology and response tomilrinone in decompensated heart failure. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(02)02968-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.